BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23127971)

  • 1. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma.
    Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; AlHilli MM; Martin JR; Keeney GL; Dowdy SC; Podratz KC
    Gynecol Oncol; 2013 Jan; 128(1):71-76. PubMed ID: 23127971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
    Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
    Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
    Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
    Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors of Uterine Serous Carcinoma-A Multicenter Study.
    Zhong X; Wang J; Kaku T; Wang Z; Li X; Wei L
    Int J Gynecol Cancer; 2018 Jul; 28(6):1138-1144. PubMed ID: 29621127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.
    Giuntoli RL; Gerardi MA; Yemelyanova AV; Ueda SM; Fleury AC; Diaz-Montes TP; Bristow RE
    Int J Gynecol Cancer; 2012 Feb; 22(2):273-9. PubMed ID: 22146771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma.
    Kommoss F; Faruqi A; Gilks CB; Lamshang Leen S; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2017 Feb; 41(2):161-170. PubMed ID: 27776011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
    Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
    Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
    [No Abstract]   [Full Text] [Related]  

  • 10. Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma.
    Li M; Li M; Zhao L; Wang Z; Wang Y; Shen D; Wang J; Wei L
    Int J Gynecol Cancer; 2016 Jul; 26(6):1092-7. PubMed ID: 27104940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
    Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
    J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
    Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
    Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.
    Felix AS; Brinton LA; McMeekin DS; Creasman WT; Mutch D; Cohn DE; Walker JL; Moore RG; Downs LS; Soslow RA; Zaino R; Sherman ME
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
    Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
    Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
    You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
    BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine serous carcinoma: a comparison of therapy for advanced-stage disease.
    Gehrig PA; Morris DE; Van Le L
    Int J Gynecol Cancer; 2004; 14(3):515-20. PubMed ID: 15228426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of surgical staging in women with uterine serous carcinoma: experience in a single institution reveals a survival benefit.
    Ball A; Chu P; Ghatage P; Nation J; Nelson G
    J Obstet Gynaecol Can; 2014 Dec; 36(12):1085-1092. PubMed ID: 25668044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.
    Nolin AC; Tian C; Hamilton CA; Casablanca Y; Bateman NW; Chan JK; Cote ML; Shriver CD; Powell MA; Phippen NT; Conrads TP; Maxwell GL; Darcy KM
    Gynecol Oncol; 2022 Jul; 166(1):90-99. PubMed ID: 35624045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
    Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
    Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors prognostic of survival in advanced-stage uterine serous carcinoma.
    Holman LL; Pal N; Iglesias DA; Soliman PT; Balakrishnan N; Klopp A; Broaddus RR; Fleming ND; Munsell MF; Lu KH; Westin SN
    Gynecol Oncol; 2017 Jul; 146(1):27-33. PubMed ID: 28465008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.